VACCINATION AGAINST THE HUMAN PAPILLOMA VIRUS. SOCIAL AND HEALTH IMPLICATIONS IN SPAIN

被引:0
作者
Narvaez-Traverso, Alicia [1 ]
机构
[1] Hosp Univ Virgen de las Nieves, Unidad Tracto Genital Inferior, Granada, Spain
来源
REVISTA ROL DE ENFERMERIA | 2008年 / 31卷 / 05期
关键词
CERVICAL CANCER; HUMAN PAPILLOMA VIRUS; VACCINATION;
D O I
暂无
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Secondary prevention of cervical cancer is carried out by means of screening programs. The possibility of primary prevention by means of a vaccination has been a reality since mid-2006. Two vaccinations exist; one tetravalent and the other bivalent. Both have proven to be capable to prevent cervical cancer precursory lesions with few secondary effects. The proscribed age to administer this vaccination for all girls, at 12 years of age, implies some treatment problems. Over the long term, there is hope for a drastic reduction in cervical cancer cases and modifications in the current screening system. Health authorities expect to meet some resistance (to this vaccination) among parents depending on their ethnic origins, moral or religious predisposition, lack of information, or fear to promote sexual promiscuity without protecting against other sexually transmitted infections, fear of possible secondary effects or concern about the young vaccination age. Acceptation is greater when family precedents of cervical cancer exist, if there are older daughters, spousal support, obligatory vaccination rules or if the age for vaccination is delayed. The authors feel the social-sanitary implications of the application of this vaccination will be important in Spain. The information which matrons and nurses provide to the general public will play a fundamental role in the correct application and acceptation of this vaccination.
引用
收藏
页码:329 / 332
页数:4
相关论文
共 27 条
[1]  
Adams M, 2007, VACCINE
[2]  
Bayas Rodriguez JM, VACUNAS PAPILOMAVIRU
[3]   A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent [J].
Brabin, Loretta ;
Roberts, Stephen A. ;
Kitchener, Henry C. .
BMC PUBLIC HEALTH, 2007, 7 (1)
[4]   Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection [J].
Brisson, Marc ;
Van de Velde, Nicolas ;
De Wals, Philippe ;
Boily, Marie-Claude .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 177 (05) :464-468
[5]  
Castellsague Pique X, 2006, VIRUS PAPILOMA HUMAN, P107
[6]  
Constantine NA, J ADOLESC HLTH, V40, P108
[7]   Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPV [J].
Dempsey, AF ;
Zimet, GD ;
Davis, RL ;
Koutsky, L .
PEDIATRICS, 2006, 117 (05) :1486-1493
[8]   Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume - Projections from the National Health Interview Survey (MMIS) [J].
Eltoum, Isam A. ;
Roberson, Janie .
CANCER CYTOPATHOLOGY, 2007, 111 (01) :34-40
[9]  
Ferlay J, 2004, GLOBOCAN 2002 CANC I
[10]   Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland [J].
French, K. M. ;
Barnabas, R. V. ;
Lehtinen, M. ;
Kontula, O. ;
Pukkala, E. ;
Dillner, J. ;
Garnett, G. P. .
BRITISH JOURNAL OF CANCER, 2007, 96 (03) :514-518